A team of NIBIB-funded researchers recently developed an AI platform that can analyze 3D pathology images to predict disease outcomes. Their method had improved performance in predicting prostate cancer outcomes when compared with traditional pathology approaches, such as analysis by expert…
Due to its high accuracy, lab-based PCR testing is the gold standard for infectious disease diagnostics. Yet PCR's availability is limited, especially in low-resource settings. New research suggests a new kind of test could be more streamlined without sacrificing performance.
Researchers have established an RNA-based method that drives cells in the body to produce therapeutic proteins and secrete them into the bloodstream. The approach could extend the lifespan of drugs in the body, reducing the burden on patients.
Learn how NIBIB’s Point of Care network has mobilized engineers and innovators across the country to create different types of tests for use in a variety of settings and communities to help overcome the COVID-19 global crisis.